158 related articles for article (PubMed ID: 23053185)
1. A novel large-sized BCR-ABL transcript in a case of chronic myeloid leukaemia characterised by a favourable clinical course.
De Matteis G; Veneri D; Aprili F; Benati M; Paviati E; Guidi GC; Pizzolo G; Tecchio C
Ann Hematol; 2013 Mar; 92(3):413-5. PubMed ID: 23053185
[No Abstract] [Full Text] [Related]
2. Major molecular response to imatinib in a patient with chronic myeloid leukemia expressing a novel form of e8a2 BCR-ABL transcript.
Tchirkov A; Couderc JL; Périssel B; Goumy C; Regnier A; Uhrhammer N; Verrelle P; Berger M
Leukemia; 2006 Jan; 20(1):167-8. PubMed ID: 16270035
[No Abstract] [Full Text] [Related]
3. A novel, variant BCR-ABL1 transcript not detected by standard real-time quantitative PCR in a patient with chronic myeloid leukaemia.
McCarron SL; Haslam K; Kelly J; Duggan C; Langabeer SE
Int J Lab Hematol; 2012 Feb; 34(1):e1-2. PubMed ID: 21692997
[No Abstract] [Full Text] [Related]
4. e6a2 BCR-ABL transcript in chronic myeloid leukemia: is it associated with aggressive disease?
Colla S; Sammarelli G; Voltolini S; Crugnola M; Sebastio P; Giuliani N
Haematologica; 2004 May; 89(5):611-3. PubMed ID: 15136228
[TBL] [Abstract][Full Text] [Related]
5. Frequency of BCR-ABL fusion transcripts in Serbian patients with chronic myeloid leukemia.
Todoric-Zivanovic B; Strnad M; Stamatovic D; Tukic L; Krtolica K; Tatomirovic Z; Djordjevic V; Bogdanovic A; Jankovic G; Magic Z
J BUON; 2011; 16(1):104-7. PubMed ID: 21674858
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of BCR/ABL variants in chronic myeloid leukemia patients using multiplex RT-PCR.
Bennour A; Ouahchi I; Moez M; Elloumi M; Khelif A; Saad A; Sennana H
Clin Lab; 2012; 58(5-6):433-9. PubMed ID: 22783572
[TBL] [Abstract][Full Text] [Related]
7. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].
Matolcsy A
Orv Hetil; 2004 Dec; 145(52):2603-9. PubMed ID: 15724695
[TBL] [Abstract][Full Text] [Related]
8. Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transcript levels in patients with chronic myeloid leukaemia.
Langabeer SE; Gale RE; Harvey RC; Cook RW; Mackinnon S; Linch DC
Leukemia; 2002 Mar; 16(3):393-9. PubMed ID: 11896544
[TBL] [Abstract][Full Text] [Related]
9. Generation of the BCR/ABL fusion gene in a Philadelphia chromosome-negative chronic myeloid leukaemia: insertion of 5.6 Mb of 9q34 into the BCR region of chromosome 22.
Valle L; Fernández V; Pérez-Pons C; Sánchez FG; Benítez J; Urioste M
Hematol Oncol; 2006 Jun; 24(2):86-8. PubMed ID: 16598834
[TBL] [Abstract][Full Text] [Related]
10. [Ten years of molecular monitoring of chronic myeloid leukemia by quantitative RT-PCR].
Moravcová J; Brdicka R
Cas Lek Cesk; 2005; 144(1):32-7. PubMed ID: 15789779
[TBL] [Abstract][Full Text] [Related]
11. Molecular monitoring of BCR-ABL as a guide to clinical management in chronic myeloid leukaemia.
Hughes T; Branford S
Blood Rev; 2006 Jan; 20(1):29-41. PubMed ID: 16426942
[TBL] [Abstract][Full Text] [Related]
12. Second case of CML with aberrant BCR-ABL fusion transcript (e8/a2) with insertion of an inverted ABL intron 1b sequence.
Sugimoto T; Ijima K; Hisatomi H; Murayama T; Mizuno I; Hato A; Imoto S; Nishimura R; Koizumi T
Am J Hematol; 2004 Oct; 77(2):164-6. PubMed ID: 15389825
[TBL] [Abstract][Full Text] [Related]
13. ABL-BCR mRNAs transcribed from chromosome 9q+ in Philadelphia-chromosome-positive chronic myeloid leukaemia.
MacKenzie E; Stewart E; Birnie GD
Leukemia; 1993 May; 7(5):702-6. PubMed ID: 8483322
[TBL] [Abstract][Full Text] [Related]
14. Relationship of the BCR gene breakpoint and the type of BCR/ABL transcript to clinical course, prognostic indexes and survival in patients with chronic myeloid leukemia.
Prejzner W
Med Sci Monit; 2002 May; 8(5):BR193-7. PubMed ID: 12011769
[TBL] [Abstract][Full Text] [Related]
15. Investigation of bcr-abl transcription by Ph-positive chronic myeloid leukemia progenitors.
Keating A
Stem Cells; 1993 Oct; 11 Suppl 3():31-3. PubMed ID: 8298475
[TBL] [Abstract][Full Text] [Related]
16. The biology of chronic myeloid leukemia.
Faderl S; Talpaz M; Estrov Z; O'Brien S; Kurzrock R; Kantarjian HM
N Engl J Med; 1999 Jul; 341(3):164-72. PubMed ID: 10403855
[No Abstract] [Full Text] [Related]
17. The presence of a BCR-ABL mutant allele in CML does not always explain clinical resistance to imatinib.
Khorashad JS; Anand M; Marin D; Saunders S; Al-Jabary T; Iqbal A; Margerison S; Melo JV; Goldman JM; Apperley JF; Kaeda J
Leukemia; 2006 Apr; 20(4):658-63. PubMed ID: 16467863
[TBL] [Abstract][Full Text] [Related]
18. [Effect of co-expressing M-bcr/abl and m-bcr/abl fusion gene transcripts on the clinical features of patients with chronic myelogenous leukemia at diagnosis].
Meng WT; Liu T; Li JJ; Shi Q; Yu J; Cui X; Wu Y; Xiang B
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):97-100. PubMed ID: 16468653
[TBL] [Abstract][Full Text] [Related]
19. [Genetic diagnosis of chronic myeloid leukemia].
Kato C; Naoe T
Nihon Rinsho; 2001 Dec; 59(12):2336-41. PubMed ID: 11766335
[TBL] [Abstract][Full Text] [Related]
20. The role of serial BCR-ABL transcript monitoring in predicting the emergence of BCR-ABL kinase mutations in imatinib-treated patients with chronic myeloid leukemia.
Wang L; Knight K; Lucas C; Clark RE
Haematologica; 2006 Feb; 91(2):235-9. PubMed ID: 16461309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]